(2025) ๋ณ‘๋ฆฌ1(A) - 4.1 Neoplasia

ํฌ๊ฒŒ 3๊ฐ€์ง€ ๊ณ„์—ด๋กœ ๋ณธ๋‹ค: Epithelial / Mesenchymal / Round cell โ†’ ๊ฐ„์—ฝ์œ ๋ž˜ ์ข…์–‘ ์ค‘ sarcoma์— ํ•ด๋‹นํ•˜๋Š” + ๋น„์Šทํ•˜๊ฒŒ ์ƒ๊ฒจ์„œ ๊ตฌ๋ถ„์ด ์–ด๋ ค์šด โ‡’ STS

๊ฐ„์—ฝ์œ ๋ž˜ ์ข…์–‘์€ โ†’

๐ŸŒฟ Mesenchymal TumorBenignMalignant
Connective tissue & Related
Fibrous connective tissue (Fibroblast)FibromaFibrosarcoma
Fat (Adipocyte)LipomaLiposarcoma
(์ •์ฒด์„ฑ ๋šœ๋ ท โ†’ STS ๋ผ๊ณ  ํ•˜์ง€ ์•Š์Œ)
Cartilage (Chondrocyte)ChondromaChondrosarcoma
Bone (Osteoblast)OsteomaOsteosarcoma
(์ •์ฒด์„ฑ ๋šœ๋ ท โ†’ STS ๋ผ๊ณ  ํ•˜์ง€ ์•Š์Œ)
Endothelium & Related
Blood vessel (Vascular endothelial cell)HemangiomaHemangiosarcoma
Lymphatic vessel (Lymphatic endothelial cell)LymphangiomaLymphangiosarcoma
Synovium (Synovial lining cell)SynoviomaSynovial sarcoma
Mesothelium (Mesothelial cell)-Mesothelioma
(์–‘์„ฑ ์—†์Œ)
Meninges (Meningeal connective tissue cell)MeningiomaMalignant meningioma
Ovary (Modified mesothelium)AdenomaAdenocarcinoma
Muscle
Smooth muscle (Smooth muscle cell)LeiomyomaLeiomyosarcoma
Skeletal muscle (Skeletal muscle cell)RhabdomyomaRhabdomyosarcoma

๋”ฐ๋ผ์„œ,

  • ์–‘์„ฑ : fibroma, leiomyoma, rhabdomyoma, lymphangioma, hemangioma, chondroma, osteoma, lipoma ๋“ฑ ๊ฐ€๋Šฅ.
  • ์•…์„ฑ : fibrosarcoma, leiomyosarcoma, rhabdomyosarcoma, lymphangiosarcoma, hemangiosarcoma, chondrosarcoma, osteosarcoma, liposarcoma ๋“ฑ
    • โ†’ ์ด๋Ÿฐ ์• ๋“ค์ด STS์— ํ•ด๋‹น
    • osteosarcoma, liposarcoma, chondrosarcoma ์ฒ˜๋Ÿผ ํŠน์ง•์ด ์•„์ฃผ ๋šœ๋ ทํ•ด์„œ ํ—ท๊ฐˆ๋ฆฌ์ง€ ์•Š๋Š” ์• ๋“ค์€ ๊ตณ์ด ์ด๋ ‡๊ฒŒ ์ด์นญํ•˜์ง€ ์•Š๋Š”๋‹ค.

์—ฐ๋ถ€์กฐ์ง์œก์ข…: Soft Tissue Sarcomas (STS) in Companion Animals

A Review of Two Key Studies

์ผ๋‹จ round cell tumor๋ณด๋‹ค ํ›จ์”ฌ!! ๊ธธ์ญ‰๊ธธ์ญ‰ํ•˜๊ณ  ํ๋ฆ„์„ ๊ฐ€์ง„ ๋“ฏ์ด ์ƒ๊ฒผ๋‹ค.
์ด ํŒจํ„ด ์ž์ฒด๊ฐ€ STS์˜ ์ „ํ˜•์ ์ธ ๋ชจ์Šต.

Canine STS Study

  • STS๋Š” ๋†’์€ ์นจ์Šต์„ฑ์ด ๋ฌธ์ œ. Sarcoma = ์ผ๋‹จ ์•…์„ฑ. ์‹ฌ์ง€์–ด ์นจ์Šต์„ฑ์ด ์•„์ฃผ ๋†’์€ ํŽธ.
  • margin์„ ์ถฉ๋ถ„ํžˆ ๋‘๊ณ  ์ ˆ์ œํ–ˆ์–ด๋„ ์žฌ๋ฐœํ•  ์ˆ˜ ์žˆ์Œ.
  • ์ „์ด๋Š” ์ž˜ ์•ˆ ๋˜๋Š” ๊ฒƒ๋„ ํŠน์ง•. ๋ฌธ์ œ๋Š” ํ•ญ์ƒ ์žฌ๋ฐœ!
  • ์š”์ฆ˜์€ ์ˆ˜์ˆ  ํ›„ ๋ฐฉ์‚ฌ์„  ์น˜๋ฃŒ๊นŒ์ง€ ์ ์šฉํ•ด๋ณด๊ณ  ์žˆ๋‹ค.

  • ์–ด๋–ค ์ข…์–‘์ด : Osteosarcoma(๊ณจ์œก์ข…), Chondrosarcoma(์—ฐ๊ณจ์œก์ข…), hemangiosarcoma(ํ˜ˆ๊ด€์œก์ข…), histiocytic sarcoma
  • โ€œSoft Tissue Sarcomaโ€๋ผ๋Š” ํ‘œํ˜„์„ ์“ฐ๋Š” ๊ฑด, (round cell tumor๋ผ๋Š” ํ‘œํ˜„๋„ ๊ทธ๋ ‡๋“ฏ) ๋‹น์žฅ ๋ช…ํ™•ํžˆ ์ง„๋‹จ๋‚ด๋ฆฌ๊ธฐ ์–ด๋ ค์šด ๊ฒƒ. osteosarcoma, chondrosarcoms๋Š” ๋น„๊ต์  ๋ช…ํ™•ํ•ด์„œ โ€˜soft tissue sarcomaโ€™๋ผ๋Š” ํ‘œํ˜„์„ ์ž˜ ์•ˆ ์“ด๋‹ค.
  • ํ•ด๋ถ€ํ•™์  ์œ„์น˜ : ๋งค์šฐ ๋‹ค์–‘ํ•˜์ง€๋งŒ ์ฃผ๋กœ ์ฝ”, ์ž…, ์‚ฌ์ง€

249 ์ค‘ Grade 2๊ฐ€ ์ ˆ๋ฐ˜
์‚ฌ์ง€ ๋ถ€์œ„๊ฐ€ ์ œ์ผ ๋งŽ์•˜๋‹ค.

Margin ํ‰๊ฐ€: 16.6%๋งŒ complete margin์ด์—ˆ๋‹ค. ๋‚˜๋จธ์ง€๋Š” ์ถฉ๋ถ„ํ•œ margin์„ ํ™•๋ณดํ•˜์ง€ ๋ชปํ•œ ๊ฒƒ. ์ข…์–‘ ํŠน์„ฑ์ƒ ์นจ์Šต์„ฑ์ด ๋งค์šฐ ๋†’๊ธฐ ๋•Œ๋ฌธ์ž„. ๋ˆˆ์œผ๋กœ ๋ณด๊ธฐ์— ์ถฉ๋ถ„ํžˆ ๋—์–ด๋„ ์กฐ์งํ•™์ ์œผ๋กœ ์ถฉ๋ถ„ํ•˜์ง€ ์•Š์„ ๋•Œ๊ฐ€ ๋งŽ์Œ.


1๋…„ ์ƒ์กด๋ฅ  : 90%
2๋…„ ์ƒ์กด๋ฅ  : 76%
3๋…„ ์ƒ์กด๋ฅ  : 60%
์žฌ๋ฐœ๋ฅ ์ด ๋†’์€ ๊ฒƒ๊ณผ ๊ด€๋ จ์ด ์žˆ๊ฒ ์ง€?

๊ตญ์†Œ์ ์œผ๋กœ ์–ด๋–ป๊ฒŒ ์ง„ํ–‰๋˜์—ˆ๋Š”์ง€
1๋…„ ๋‚ด progression ์—†์„ ํ™•๋ฅ  ๋†’์Œ

ํ์ „์ด๋Š” 10% ์ •๋„. ํ•ญ์ƒ ์žฌ๋ฐœ์ด ๋ฌธ์ œ์ธ ์ข…์–‘.
grade๊ฐ€ ๋†’์•„์งˆ์ˆ˜๋ก ์ „์ด ํ™•๋ฅ ์€ ๋†’์•„์ง€๊ณ , grade 3๋Š” 30%์— ์œก๋ฐ•.
์กฐ์งํ•™์  ์†Œ๊ฒฌ์€ ๊ฒฝ๊ณผ ์˜ˆ์ƒ๊ณผ ์ „์ด์—ฌ๋ถ€๋ฅผ ํŒ๋‹จํ•  ๋•Œ๋„ ์ค‘์š”.


Histological grade๋Š” local progression๊ณผ ์œ ์˜์ ์ธ ์ƒ๊ด€๊ด€๊ณ„ ์—†์—ˆ์Œ
grade ์ƒ๊ด€์—†์ด progression ๋†’์Œ
grade 1์ด์–ด๋„ ์นจ์Šต์„ฑ ๋†’๊ณ , ๊ตญ์†Œ ์ง„ํ–‰๊ณผ ์žฌ๋ฐœ ์‰ฌ์›€


ํ‘œํ”ผ-์ง„ํ”ผ-ํ”ผํ•˜์ง€๋ฐฉ์กฐ์ง์„ ๋ฉ์–ด๋ฆฌ๊ฐ€ ๋Œ€์ฒดํ•˜๊ณ  ์žˆ์Œ.
์ด ๊ฒฝ์šฐ๋Š” ์ฃผ๋ณ€๊ณผ ๊ฒฝ๊ณ„ ์ข‹์€ ํŽธ.
์ฃผ๋ณ€ ์ •์ƒ ์กฐ์ง๊ณผ ๋น„๊ต์  ์–‘ํ˜ธํ•œ ๊ฒฝ๊ณ„๋ฅผ ๊ฐ€์ง€๊ณ  ์žˆ๋Š” ์ข…์–‘์„ฑ ์ข…๊ดด๊ฐ€ ๊ด€์ฐฐ๋˜์—ˆ๋‹ค.


๋ฆผํ”„๊ตฌ๊ฐ€ ๋™์›๋œ ๋ถ€๋ถ„์€ ์ •์ƒ์ ์œผ๋กœ
๋‚˜๋จธ์ง€ ๊ณต๊ฐ„๋“ค์ด ๊ฝ‰ ์ฐจ ์žˆ๋‹ค

  • ์ƒํ”ผ์„ธํฌ ์ข…์–‘์€ ์ข…์–‘๋“ค์ด ๋ชจ์—ฌ์„œ ์–ด๋–ค ๊ตฌ์กฐ๋ฅผ ์ด๋ฃจ๊ณ  ์žˆ์—ˆ๊ณ 
  • round cell tumor๋Š” ๋นฝ๋นฝํ•˜๊ฒŒ ๋ชจ์—ฌ ์žˆ์—ˆ๊ณ 
  • soft tissue sarcoma๋Š” ์–ด๋–ค ํ๋ฅด๋Š” ๋ฐฉํ–ฅ์„ ํ˜•์„ฑํ•˜๊ณ  ์žˆ๋‹ค (๊ต์ฐจํ•˜๋ฉด inter.. patter, streaming pattern))

์–˜๋„ค๋Š” ๋Œ€์ฒด์ ์œผ๋กœ ์„ธํฌ๋“ค์ด ๊ธธ์ญ‰๊ธธ์ญ‰ํ•ด ๋ณด์ด๊ณ , ์ฆ์‹ํ•˜๋Š” ํŒจํ„ด์ด ๋ฌผ์ด ํ๋ฅด๋Š” ๋“ฏํ•œ ํŒจํ„ด
์ž‘๊ณ  ๋™๊ธ€๋™๊ธ€ํ•œ ์• ๋“ค์€ ๋ฉด์—ญ์„ธํฌ(๋ฆผํ”„๊ตฌ, plasma cell)
๋‚˜๋จธ์ง€๋ฅผ ๋ณด๋ฉด ์„ธํฌ๋“ค์ด ๊ธธ์ญ‰ํ•˜๊ณ , ํ•ต๋„ ํƒ€์›ํ˜•
ํ•ต์„ ๋ณด๋ฉด ํ•ต ์•ˆ์— ํ•ต์†Œ์ฒด๊ฐ€ ์ง„ํ•˜๊ณ  ํฌ๋‹ค
ํ•ต์€ ํƒ€์›ํ˜•๋„ ์žˆ๊ณ  ์›ํ˜•๋„ ์žˆ์ง€๋งŒ ๊ทธ๊ฑด ์ฃผํ–‰ ๋ฐฉํ–ฅ์ด ๋‹ค๋ฅด๊ธฐ ๋•Œ๋ฌธ
์›ํ˜• ํ•ต๊ณผ ์—ผ์ฆ์„ธํฌ๋Š” ๋˜ ๋‹ค๋ฅด๊ฒŒ ์ƒ๊น€. ์ข…์–‘์„ธํฌ ํ•ต์€ ์•ˆ์ด ์ข€ ๋” ๋น„์–ด ๋ณด์ž„.
์กฐ์งํ•™์  ๊ฒ€์‚ฌ๋Š” 2์ฐจ์›์ด๋ฏ€๋กœ 3์ฐจ์› ์ฃผํ–‰ ๋ฐฉํ–ฅ์„ ํฌํ•จํ•ด์„œ ์ƒ๊ฐํ•  ๊ฒƒ.

ํ•ด๋ง๋ณธ ํŒจํ„ด. ๊ฐ€์šด๋ฐ ์ฒ™์ถ”๋ฅผ ๋‘๊ณ  ๋ป—์–ด๋‚˜๊ฐ€๋Š” ๋“ฏํ•œ.
์ƒ์„  ๋“ฑ๋ผˆ ๊ฐ™์€ ํŒจํ„ด
soft tissue sarcoma๋Š” ์„ธํฌ์™€ ์„ธํฌ ์‚ฌ์ด ๊ฒฝ๊ณ„๊ฐ€ ๋ถˆ๋ถ„๋ช…ํ•จ

์ƒํ”ผ์„ธํฌ ์œ ์„  ์ข…์–‘ / round cell tumor / soft tissue sarcoma
์ „์ฒด์ ์ธ ํŒจํ„ด์ด๋‚˜ ๊ตฌ์กฐ๋งŒ ๋ด๋„ ์ด๋ ‡๊ฒŒ ์ข€ ๋‚˜๋‰œ๋‹ค


  • Grade :
  • Stage : ์ž„์ƒ์—์„œ ํ™˜์ž์— ์ƒ๊ธด ์งˆ๋ณ‘์„ ํŒ๋‹จํ•˜๋Š” ๊ธฐ์ค€
    • ๊ตญ์†Œ์ , ์‚ฌ์ด์ฆˆ, ์ „์ด ์—ฌ๋ถ€ ๋“ฑ
    • ํŒ”๋กœ์—…ํ•ด์„œ ์ƒํƒœ ํŒŒ์•…ํ•˜๋Š” ๊ฒŒ ์ค‘์š”
  • Margin : ์œก์•ˆ ํŒ๋‹จ < ๋ณ‘๋ฆฌํ•™์  ํŒ๋‹จ

์ •ํ™•ํ•œ ์ง„๋‹จ๋ช… + ์กฐ์งํ•™์  grade + ์ ˆ์ œ margin + clinical follow-up(์ถ”์ ๊ด€์ฐฐ) Soft tissue sarcoma๋Š” ์™œ โ€œgroupโ€์ธ๊ฐ€? ๋ผˆ ์œ ๋ž˜, ์—ฐ๊ณจ ์œ ๋ž˜,ํ™•์‹คํžˆ ๊ตฌ๋ถ„๋˜๋Š” ๊ฒƒ ๋ง๊ณ  ์• ๋งคํ•œ ์• ๋“ค์„ ์ผ๋‹จ group์œผ๋กœ ๋ณด์ž„.

์„ฑ์žฅ ํŒจํ„ด์˜ ํŒ๋‹จ : soft tissue sarcoma๋Š” ๋ฌผ๊ฒฐ์น˜๋“ฏ ํ๋ฆ„์„ ๊ฐ€์ง€๊ณ  ๊ธธ์ญ‰ํ•˜๊ฒŒ ์„ฑ์žฅํ•œ๋‹ค. (whorls, storiform pattern)

  • pseudocapsule

์–‡์€ ๊ฒฐํ•ฉ์กฐ์ง์ด ๋ฉ์–ด๋ฆฌ๋ฅผ ๋‘˜๋Ÿฌ์‹ธ๊ณ  ์žˆ๋Š” ๋А๋‚Œ. ์–‡์€ capsulation = ์–‘์„ฑ ์œ ์„  ์ข…์–‘์„ ํŒ๋‹จํ•˜๋Š” ์ฃผ์š” ๊ธฐ์ค€์ด์—ˆ๋‹ค STS์—์„œ๋Š” โ€˜pseudocapsuleโ€™์ด๋ผ๊ณ  ๋ถ€๋ฅด๋Š”๋ฐ, ์•ฝ๊ฐ„ ์‚์ฃฝ์‚์ฃฝํ•˜๊ฒŒ ํŒŒ๊ณ ๋“ค์–ด๊ฐ€๊ณ , ์ข…์–‘์„ธํฌ๊ฐ€ ์ฃผ๋ณ€์— ๋Œ€ํ•œ capsule์„ ๋งŒ๋“ ๋‹ค. (์œ ์„ ์ข…์–‘๋•Œ๋Š” host๊ฐ€ ๋ฐฉ์–ด๋ฅผ ์œ„ํ•ด ๋งŒ๋“  capsule์ด์—ˆ๋Š”๋ฐ), ์ด๊ฑด ์ข…์–‘์„ธํฌ๊ฐ€ ์ž๊ธฐ ์„ฑ์งˆ์„ ์œ ์ง€ํ•˜๋ฉด์„œ ๋งŒ๋“  ๋‹จ์ˆœํ•œ ํ…Œ๋‘๋ฆฌ. ์ฃผ๋ณ€๊ณผ ๊ฒฝ๊ณ„๊ฐ€ ์ž˜ ๋˜์–ด ์žˆ์ง€๋งŒ, ๋•Œ์— ๋”ฐ๋ผ์„œ capsulation์ด ์ž˜ ๋˜์–ด ์žˆ๋‹ค๋Š” ๋ง์€ ์œ„ํ—˜

์ „์ด๊ฐ€ ๋น„๊ต์  ๋“œ๋ฌผ์ง€๋งŒ, grade๊ฐ€ ๋†’์„์ˆ˜๋ก ์ „์ด์œจ์ด ๋†’์•„์ง„๋‹ค.

์ž๊ธฐ๋„ค๋ผ๋ฆฌ ๋‹ค๋ฐœ์„ ํ˜•์„ฑ, ๋‹ค๋ฐœ๋“ค์ด ๋ฌผ๊ฒฐ์น˜๋“ฏ ๊ฐ์ž์˜ ๋ฐฉํ–ฅ์œผ๋กœ ํ๋ฅด๊ณ  ์žˆ๋‹ค๋Š” ๊ฒƒ์ด ํŠน์ง•.

๊ฒฐํ•ฉ์กฐ์ง, mesoderm ์œ ๋ž˜๊ฐ€ STS์˜ ์›๋ž˜ ์ •์˜์ง€๋งŒ ์ž๊ธฐ ์ •์ฒด์„ฑ์ด ํ™•์‹คํ•œ ์• ๋“ค์€ ๋“ค์–ด๊ฐ€์ง€ ์•Š๋Š”๋‹ค (exclude)

Included: STS์˜ ๋ฒ”์ฃผ์— ํฌํ•จExclude:
spinal nerve/root ์œ ๋ž˜
chondrosacroma/osteosasrcoma
  • Pathology report ๋‚ด์šฉ
    • grade์™€ margin์„ ๊ณ ๋ คํ•ด์„œ ์˜ˆํ›„๋ฅผ ์‚ฐ์ •ํ•จ.
    • complete vs. incomplete margin ๋งค์šฐ ์ค‘์š”.
    • grade๊ฐ€ ๋†’์„์ˆ˜๋ก ์ „์ด์œจ์ด ๋†’์•„์ง„๋‹ค.
    • surgical margin์ด ์–ผ๋งˆ๋‚˜ ํ™•๋ณด๋˜์–ด ์žˆ๋Š”์ง€๋„ ์จ์ฃผ๋Š” ์ถ”์„ธ.
      • ์กฐ์ง ์Šฌ๋ผ์ด๋“œ ๋งŒ๋“ค๋ฉด์„œ ๊ณ„์† ์ˆ˜์ถ•ํ•˜๊ธฐ ๋•Œ๋ฌธ์— ์กฐ๊ธˆ ์ฐจ์ด๋‚  ์ˆ˜ ์žˆ์Œ.
    • pattern ๋ชจ์–‘์— ๋”ฐ๋ผ ์˜ˆํ›„๊ฐ€ ๋‹ฌ๋ผ์ง€์ง„ ์•Š์Œ (herring, streaming, whorl pattern..)
    • tumor emboli ์†Œ๊ฒฌ๊นŒ์ง€ ํฌํ•จ๋˜์–ด์•ผ ํ•จ.

[Grading]

  • ๊ธฐ์ค€ 1) Differentiation (๊ฐ€์žฅ ์ฃผ๊ด€์ ์ธ ํŽธ; ๊ตฌ๋ถ„์ด ๋ช…ํ™•ํžˆ ๋˜๋ฉด ๋‚ฎ์€ ์ ์ˆ˜, ๊ตฌ๋ถ„์ด ์ž˜ ์•ˆ ๋˜๋ฉด ๋†’์€ ์ ์ˆ˜)

  • ๊ธฐ์ค€ 2) Mitotic count (์„ธํฌ๊ฐ€ ์–ผ๋งˆ๋‚˜ ๋นจ๋ฆฌ ๋ถ„์—ดํ•˜๋Š”์ง€)

  • ๊ธฐ์ค€ 3) Necrosis (๊ดด์‚ฌ๋œ ์ •๋„)

  • Mitotic count

    • ์ƒ‰์ด ์ง„ํ•˜๊ณ  ๊ธธ์ญ‰ํ•œ ๊ฒƒ๋“ค์ด ์žˆ์ง€๋งŒ
    • ๊ฐ€์šด๋ฐ ์žˆ๋Š” ๊ฒŒ ๋ถ„์—ด์ƒ.
    • Chromatin์€ ์‹ค ๊ฐ™์€ ๋ชจ์–‘์ด์–ด์„œ, ๊ฐ€์žฅ์ž๋ฆฌ๊ฐ€ ๋งค๋ˆํ•  ์ˆ˜ ์—†์Œ. ํ„ธ์‹ค์ด ๋‚˜ํ’€๊ฑฐ๋ฆฌ๋Š” ๋“ฏํ•œ ๊ฐ€์žฅ์ž๋ฆฌ๋ฅผ ๋ณด์ž„.
    • 2.37mm^[2] ์˜ 10๊ตฐ๋ฐ(10HPF)์—์„œ 10๊ฐœ ๋ฏธ๋งŒ์ด๋ฉด 1,
    • ์˜ˆ์ „์—๋Š” โ€œmitotic indexโ€๋ผ๊ณ  ํ–ˆ์ง€๋งŒ ์š”์ฆ˜์€ ๊ณต์‹์ ์œผ๋กœ โ€œmitotic countโ€
  • Tumor necrosis

    • ๋ณด๋ผ์ƒ‰ ํ…Œ๋‘๋ฆฌ๋Š” ์ข…์–‘์„ธํฌ, ๊ทธ ์•„๋ž˜๋กœ ์ถœํ˜ˆ๊ณผ ๊ดด์‚ฌ์†Œ.
    • ์—†์œผ๋ฉด 0, ์ ˆ๋ฐ˜ ์ดํ•˜๋ฉด 1, ํ›จ์”ฌ ๋„“๊ฒŒ ์žˆ์œผ๋ฉด 2
  • ์„ธ๊ฐ€์ง€ ์š”์†Œ์˜ score๋ฅผ ํ•ฉ์‚ฐํ•ด์„œ grade๋ฅผ ๋งค๊น€. ์™„์ „ํžˆ ์‹ ๋ขฐํ•  ์ˆ˜๋Š” ์—†์Œ.

  • Margin : ์ฃผ๋ณ€์กฐ์ง์„ ํฌํ•จํ•ด์„œ ์ข‹์€ surgical margin. ์œ„ ์‚ฌ์ง„์€ ์ฃผ๋ณ€ ์ •์ƒ์กฐ์ง์ด ์ „ํ˜€ ํฌํ•จ๋˜์ง€ ์•Š์Œ.

  • Grade โ…ก+ margin์€ ์ž˜ ํ™•๋ณด๋˜์ง€ ์•Š์•˜๋‹ค, ๋ผ๊ณ  ๋ฆฌํฌํŠธ ๋œ ๊ฒŒ ์ข‹์Œ.

์ง„๋‹จ ํ™•์ • โ†’ grade & margin ํ‰๊ฐ€ โ†’

Feline STS : ํ›จ์”ฌ ์• ๋งคํ•˜๋‹ค. ๊ฐœ์˜ ๊ธฐ์ค€์„ ๊ทธ๋Œ€๋กœ ์ ์šฉํ•  ์ˆ˜ ์—†๋‹ค.

ํ”ผํ•˜์ฃผ์‚ฌ๋ฅผ ํ•œ ๋ถ€์œ„์— STS๊ฐ€ (๊ฐœ์— ๋น„ํ•ด ํ›จ์”ฌ) ์ž˜ ์ƒ๊ธด๋‹ค. ์ฃผ์‚ฌ ๋ถ€์œ„๊ฐ€ ๋ชฉ์ด ํ‰ํ‰ ๋ถ€์–ด์„œ ์™”๋‹ค๋ฉด? ํ”ผํ•˜์ง€๋ฐฉ์ธต์—ผ์ผ ์ˆ˜๋„ ์žˆ์ง€๋งŒ,์•ˆ์‹ฌํ•  ์ˆ˜ ์—†๋‹ค - sarcoma๋กœ ์ž˜ ๋ฐœ์ „ํ•จ. feline system = mitosis + necrosis + inflammation (์—ผ์ฆ๊นŒ์ง€ ๊ฐ™์ด ๊ณ ๋ คํ•˜๋Š” ๊ฒŒ ์•ˆ์ „ํ•˜๋”๋ผ) differentiation ๋Œ€์‹  ์—ผ์ฆ์ด ์‹ฌํ•œ์ง€ score๋ฅผ ๋„ฃ๊ธฐ ์‹œ์ž‘ ์ฃผ์‚ฌ๋ถ€์œ„ ์—ผ์ฆ์ด ์ค‘์š”ํ•˜๊ธฐ ๋•Œ๋ฌธ ๋ชฉ๋œ๋ฏธ์— ์ฃผ์‚ฌํ–ˆ๋Š”๋ฐ ํ”ผํ•˜์ง€๋ฐฉ์ธต์„ ๋”ฐ๋ผ ์•„๋ž˜๋กœ ๋‚ด๋ ค๊ฐˆ ์ˆ˜ ์žˆ๋‹ค.,๊ฐ™์€ Z์ถ•์ƒ์— ์žˆ์œผ๋ฉด ์ด ๋˜ํ•œ ์•ฝ์ œ์— ์˜ํ•œ ๋ณ€ํ™”์ผ ์ˆ˜ ์žˆ๋‹ค. ๊ณ ์–‘์ด์—์„œ๋Š” FISS๊ฐ€ ๋นˆ๋ฒˆํ•˜๊ฒŒ ๊ด€์ฐฐ๋˜๊ธฐ ๋•Œ๋ฌธ์— ์—ผ์ฆ์„ ๋ฐ˜๋“œ์‹œ ๊ณ ๋ ค.

STS์™€ FISS๋ฅผ ๋”ฐ๋กœ ์ƒ๊ฐํ•ด์•ผ ํ•˜์ง€ ์•Š๋ƒ๋Š” ๋…ผ์˜๋„ ๋‚˜์˜ค๊ณ  ์žˆ๋‹ค. Injection ๊ณผ ๋ฌด๊ด€ํ•œ STS์™€, injection-re STS์˜ ํŠน์ง•์ด ๋‹ค๋ฅด์ง€ ์•Š๊ฒ ๋‚˜. non-FISS STS, FISS

์˜ˆํ›„๋Š” ์—ฌ๋Ÿฌ ๊ฐ€์ง€๋ฅผ ์ข…ํ•ฉํ•ด์„œ ํŒ๋‹จ, grade๋งŒ ๋ณด๊ณ  ํŒ๋‹จํ•  ์ˆ˜ ์—†๋‹ค.

๐Ÿ”ฌ Rt_rib_region_sc_mass_1

  • Differentiation : ๋ฌด์Šจ ์„ธํฌ์ธ์ง€ ๊ตฌ๋ถ„์ด ์ž˜๋˜๋Š”์ง€
    • fibrosarcoma, perivascular wall tumor (ํ˜ˆ๊ด€๋ฒฝ์„ ์ด๋ฃจ๋Š” ์„ธํฌ์—์„œ ์†Œ์šฉ๋Œ์ด์น˜๋“ฏ ๋‚˜์˜ค๋Š”)
    • ์–ด๋–ค ์„ธํฌ๊ฐ€ ์–ด๋–ค ํŠน์ง• ๋•Œ๋ฌธ์—? ๋ผ๊ณ  ๋งํ•  ์ˆ˜ ์žˆ์–ด์•ผ ๋ถ„ํ™”๋„๊ฐ€ ์ข‹์€ ๊ฒƒ.
  • Mitotic Count : ์—†์Œ
  • Necrosis : ๊ดด์‚ฌ ์—†์Œ. ์ƒ‰๊น”์ด ์ข€ ํ๋ฆฟํ•œ ๋ถ€์œ„๋Š” ์žˆ์ง€๋งŒ ๊ณ ๋ฐฐ์œจ์—์„œ ๋ณด๋ฉด ๊ทธ๋ ‡๊ฒŒ ๋ณด์ด์ง€ ์•Š์Œ.
  • Grade โ… ์œผ๋กœ ํŒ๋‹จ.
  • (๋งŒ์•ฝ ๊ณ ์–‘์ด๋ผ๋ฉด) ํ˜ˆ๊ด€ ์ฃผ๋ณ€์— ์—ผ์ฆ์„ธํฌ ์กฐ๊ธˆ ์กด์žฌ = ์ด์ •๋„๋ฉด ์—ผ์ฆ 1. capsule์ด ๋‘๊บผ์›Œ ๋ณด์ด์ง€๋งŒ, ์œ„๋ฅผ ๋”ฐ๋ผaedsfsf ์˜ฌ๋ผ๊ฐ€ ๋ณด๋ฉด ์ข…์–‘์—์„œ ๋งŒ๋“  pseudocapsule์ž„์„ ์•Œ ์ˆ˜ ์žˆ๋‹ค.